Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 05, 2022

SELL
$1.48 - $2.64 $3,256 - $5,808
-2,200 Closed
0 $0
Q1 2022

May 11, 2022

BUY
$2.0 - $2.87 $4,400 - $6,314
2,200 New
2,200 $6,000

Others Institutions Holding XERS

About Xeris Biopharma Holdings, Inc.


  • Ticker XERS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 135,956,992
  • Market Cap $420M
  • Description
  • Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies for patient populations in endocrinology, neurology, and gastroenterology. The company markets Gvoke, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, h...
More about XERS
Track This Portfolio

Track Ovata Capital Management LTD Portfolio

Follow Ovata Capital Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ovata Capital Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Ovata Capital Management LTD with notifications on news.